Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia.
- Journal
- PubMed
In The Last Decade
doi.org/w83534547 →Countries where authors are citing Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia.
This map shows the geographic impact of Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia. more than expected).
Fields of papers citing Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia.
This network shows the impact of Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia..
About Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia.
This paper, published in 1979, received 410 indexed citations . Written by Makoto Inaba, Harumi Kobayashi, Yoshio Sakurai and Randall K. Johnson covering the research area of Oncology, Public Health, Environmental and Occupational Health and Infectious Diseases. It is primarily cited by scholars working on Oncology (298 citations), Molecular Biology (256 citations) and Infectious Diseases (45 citations). Published in PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/w83534547.